RecruitingNot applicableNCT06081647

The Efficacy and Safety of the COMBO Endoscopy Oropharyngeal Airway in Gastrointestinal Endoscopy Procedure

Studying Carcinoma of esophagus

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: RenJi Hospital
Intervention: the COMBO Endoscopy Oropharyngeal Airway(device)
Enrollment: 1200 target
Eligibility: 18-60 years · All sexes
Timeline: 2023 – 2025

Study locations (10)

The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China
The First Affiliated Hospital Of Nanchang University, Nanchang, Jiangxi, China
Shangdong Provincial Qianfoshan Hospital, Jinan, Shandong, China
Fudan University Shanghai Cancer Center, Shanghai, Shanghai Municipality, China
Renji Hospital, Shanghai, Shanghai Municipality, China
Tongji Hospital Of Tongji University, Shanghai, Shanghai Municipality, China
Xinhua Hospital Affliated To Shanghai Jiaotong University School Of Medicine, Shanghai, Shanghia, China
The First Affliated Hospital of Xi'an Jiangtong University, Xi’an, Shanxi, China
Tianjin Mediacal University General Hospital, Tianjin, Tianjin Municipality, China
The First Affliated Hospital, Zhejiang University School Of Medicine, Hangzhou, Zhejiang, China

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06081647 on ClinicalTrials.gov

Other trials for Carcinoma of esophagus

Additional recruiting or active studies for the same condition.

See all trials for Carcinoma of esophagus →

← Back to all trials